Periodic Reporting for period 4 - PREDICT (PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials)

Neuroblastoma are pediatric tumors that respond poorly to chemotherapy and have a very poor prognosis. To improve treatment options, a global development towards precision medicine is ongoing. We aimed to test if combinations of targeted compounds can cause complete remission...